BASF, Novozymes and DuPont are among the companies that see opportunities in biocatalysts, which speed chemical reactions and aid pharmaceutical manufacturing. The market for these enzymes could reach $5 billion per year, according to this article. BASF now has pharmaceutical enzyme manufacturing lines in the U.S., India and Italy.

Full Story:
The Motley Fool

Related Summaries